National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings, 36871 [2020-13097]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 118 / Thursday, June 18, 2020 / Notices
Dated: June 12, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–13095 Filed 6–17–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; NSD–B Conflict SEP.
Date: July 1, 2020.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Neuroscience Center, 6001
Executive Blvd., North Bethesda, MD 20852
(Video Assisted Meeting).
Contact Person: Joel A. Saydoff, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH NSC, 6001 Executive Blvd.,
Room 3205, MSC 9529, Bethesda, MD 20892,
(301)–496–9223, joel.saydoff@nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; R13 Review.
Date: July 6, 2020.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Neuroscience Center, 6001
Executive Blvd., North Bethesda, MD 20852
(Video Assisted Meeting).
Contact Person: Li Jia, Ph.D., Scientific
Review Officer, Scientific Review Branch,
Division of Extramural Research, NINDS/
NIH, 6001 Executive Boulevard, Room
3208D, Rockville, MD 20852, 301–451–2854,
li.jia@nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; NSD–K: Clinical Trials in
Neurological Disorders.
Date: July 7, 2020.
Time: 9:00 a.m. to 3:00 p.m.
VerDate Sep<11>2014
17:40 Jun 17, 2020
Jkt 250001
Agenda: To review and evaluate grant
applications.
Place: Neuroscience Center, 6001
Executive Blvd., North Bethesda, MD 20852
(Video Assisted Meeting).
Contact Person: Shanta Rajaram, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH NSC, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, Md 20892,
(301) 435–6033, rajarams@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: June 12, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–13097 Filed 6–17–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; Specimen Resource Locator
(National Cancer Institute)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
requirement of the Paperwork
Reduction Act of 1995 to provide
opportunity for public comment on
proposed data collection projects, the
National Institutes of Health, National
Cancer Institute (NCI) will publish
periodic summaries of propose projects
to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 60 days of the date of this
publication.
SUMMARY:
To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Joanne Demchok, Program
Director, Cancer Diagnosis Program,
Division of Cancer Treatment and
Diagnosis, 9609 Medical Center Drive,
Rockville, Md 20892 or call non-toll-free
number 240–276–5959 or Email your
request, including your address to:
peterjo@mail.nih.gov. Formal requests
for additional plans and instruments
must be requested in writing.
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
36871
Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: Written
comments and/or suggestions from the
public and affected agencies are invited
to address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimizes
the burden of the collection of
information on those who are to
respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Proposed Collection Title: Specimen
Resource Locator (NCI), 0925–0703:
Expiration Date 11/30/2020, REVISION,
National Cancer Institute (NCI),
National Institutes of Health (NIH).
Need and Use of Information
Collection: The availability of
specimens and associated data is critical
to increase our knowledge of cancer
biology, and to translate important
research discoveries to clinical
application. The development of
molecular technologies in cancer
patients, with defined molecular
abnormalities, advances identification
and development of clinically useful
biomarkers and diagnostic assays that
guide treatment.
The discovery and validation of
cancer prevention markers require
access, by researchers, to quality clinical
biospecimens. In response, to this need,
NCI’s Cancer Diagnosis Program
developed, and is expanding, a
searchable database: Specimen Resource
Locator (SRL) https://
specimens.cancer.gov/tissue/
default.htm. The SRL allows scientist in
the research community and the NCI to
locate specimens needed for their
research. The SRL lists all NCI
supported and non-NCI supported
biospecimens repositories and their
links. It is not NCI’s intent to collect the
biospecimens; rather the collections are
descriptions of the available data that
can act as a resource and be shared with
researchers and scientists who are
interested. This submission does not
involve any analysis.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
SUPPLEMENTARY INFORMATION:
E:\FR\FM\18JNN1.SGM
18JNN1
]]>Agencies
[Federal Register Volume 85, Number 118 (Thursday, June 18, 2020)]
[Notices]
[Page 36871]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-13097]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; NSD-B Conflict SEP.
Date: July 1, 2020.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Neuroscience Center, 6001 Executive Blvd., North
Bethesda, MD 20852 (Video Assisted Meeting).
Contact Person: Joel A. Saydoff, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural
Activities, NINDS/NIH NSC, 6001 Executive Blvd., Room 3205, MSC
9529, Bethesda, MD 20892, (301)-496-9223, [email protected].
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; R13 Review.
Date: July 6, 2020.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Neuroscience Center, 6001 Executive Blvd., North
Bethesda, MD 20852 (Video Assisted Meeting).
Contact Person: Li Jia, Ph.D., Scientific Review Officer,
Scientific Review Branch, Division of Extramural Research, NINDS/
NIH, 6001 Executive Boulevard, Room 3208D, Rockville, MD 20852, 301-
451-2854, [email protected].
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; NSD-K: Clinical Trials in
Neurological Disorders.
Date: July 7, 2020.
Time: 9:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Neuroscience Center, 6001 Executive Blvd., North
Bethesda, MD 20852 (Video Assisted Meeting).
Contact Person: Shanta Rajaram, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural
Activities, NINDS/NIH NSC, 6001 Executive Blvd., Suite 3208, MSC
9529, Bethesda, Md 20892, (301) 435-6033, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: June 12, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-13097 Filed 6-17-20; 8:45 am]
BILLING CODE 4140-01-P
